SCHEMBL751024

SCHEMBL751024

CCOC=C(C)C=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2716472 1.00
SCHEMBL4767183 1.00
SCHEMBL9058494 0.80
SCHEMBL9058495 0.80
SCHEMBL9058982 0.77 ALDH1A1 (0.41)
SCHEMBL9947095 0.76
SCHEMBL6949897 0.74
SCHEMBL6949892 0.74
SCHEMBL9058918 0.73
SCHEMBL13588368 0.73 GLO1 (0.34)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 307 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-108373468-B Preparation method of N-2-pyridine-5-pyrimidine methylamine 武汉工程大学 2019-12-17 CN claimed
CN-108947967-A A kind of preparation method of Lansoprazole 威海迪素制药有限公司 2018-12-07 CN claimed
EP-1422218-A1 ANTIVIRAL AGENT SHIONOGI & CO., LTD. (JP) 2004-05-26 EP claimed
US-20020120143-A1 Process for the preparation of 2,3-pyridinedicarboximides INTELLECTUAL PROPERTY DEPARTMENT, BASF AKTIENGESELLSCHAFT (DE) 2002-08-29 US claimed
EP-0812843-B1 Process for the preparation of 2,3-pyridinedicarboximides BASF AG (DE) 2002-01-30 EP claimed
US-6316629-B1 AS CHEMICAL INTERMEDIATES TO OBTAIN HERBICIDES AMERICAN CYANAMID CO. 2001-11-13 US claimed
EP-0812843-A2 Process for the preparation of 2,3-pyridinedicarboximides American Cyanamid Company (US) 1997-12-17 EP claimed
EP-0518724-B1 Dithiane substituted propenals and process for their preparation OREAL (FR) 1996-11-13 EP claimed
US-12528819-B2 Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment AGENEBIO, INC. (US) 2026-01-20 US disclosed
US-12291535-B2 Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment AGENEBIO, INC. (US) 2025-05-06 US disclosed
US-12227507-B2 Pharmaceutical compounds PFIZER INC. (US) 2025-02-18 US disclosed
CN-114555604-B Pharmaceutical compounds 辉瑞公司 2024-11-15 CN disclosed
US-12024525-B2 Benzodiazepine derivatives, compositions, and methods for treating cognitive impairment AGENEBIO, INC. (US) 2024-07-02 US disclosed
CN-112601749-B Benzodiazepine derivatives, compositions and methods for treating cognitive impairment 艾吉因生物股份有限公司 2024-03-26 CN disclosed
EP-0215063-A1 PYRIDO (2,3-d )PYRIMIDIN DERIVATIVES. UNIV PRINCETON (US) 1987-03-25 EP disclosed
WO-1986005181-A1 PYRIDO AD2,3-d BDPYRIMIDIN DERIVATIVES THE TRUSTEES OF PRINCETON UNIVERSITY (US) 1986-09-12 WO disclosed
EP-0031796-B1 4-HETEROCYCLYL-4'-VINYL-STILBENES CIBA-GEIGY AG (CH) 1985-01-23 EP disclosed
EP-0102823-A2 Herbicidal cyclohexane-1,3-dione derivatives ICI AUSTRALIA LIMITED (AU) 1984-03-14 EP disclosed
US-4366189-A WHITENERS CIBA-GEIGY CORPORATION (US) 1982-12-28 US disclosed
US-4321387-A Process for the preparation of optically active nicotine analogs PHILIP MORRIS, INCORPORATED (US) 1982-03-23 US disclosed